Document:ICH ICH E2A Guideline 1994: Difference between revisions
From GxPlex
gxplex>GxPlexBot Import from GxPlex Excel |
Remove static References table, superseded by live #ask in Template:DocumentData (GxPlexBot) |
||
| (9 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{DocumentData | |||
|reference=ICH ICH E2A Guideline 1994 | |reference=ICH ICH E2A Guideline 1994 | ||
|validity_area=ICH | |validity_area=ICH | ||
| Line 31: | Line 15: | ||
|contributors= | |contributors= | ||
}} | }} | ||
Latest revision as of 14:15, 16 July 2026
| Document information | |
|---|---|
| Reference | ICH ICH E2A Guideline 1994 |
| Validity area | ICH |
| Scope(s) | G |
| Document name | ICH E2A Guideline |
| Version / Revision | 1994 |
| Status | Current |
| Document type | International guideline |
| Language(s) | EN |
| Description | CLINICAL SAFETY DATA MANAGEMENT: DEFINITIONS AND STANDARDS FOR EXPEDITED REPORTING
E2A |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
References
| Scope | Document part | Language | Preview | |
|---|---|---|---|---|
| ICH ICH E2A Guideline 1994 II A. 3. | G | II A. 3. | EN | Unexpected Adverse Drug Reaction An adverse reaction, the nature or severity of which is not consistent with the applicable product information (e.g.,… |
| ICH ICH E2A Guideline 1994 II B. Serious Adverse Event or Adverse Drug Reaction | G | II B. Serious Adverse Event or Adverse Drug Reaction | EN | Serious Adverse Event or Adverse Drug Reaction During clinical investigations, adverse events may occur which, if suspected to be medicinal product-re… |
| ICH ICH E2A Guideline 1994 II B. Serious/Severe | G | II B. Serious/Severe | EN | […] To ensure no confusion or misunderstanding of the difference between the terms "serious" and "severe," which are not synonymous, the following not… |
| ICH ICH E2A Guideline 1994 III A. 1. | G | III A. 1. | EN | [...] Causality assessment is required for clinical investigation cases. All cases judged by either the reporting health care professional or the spon… |
| ICH ICH E2A Guideline 1994 III A. 2. | G | III A. 2. | EN | 2. Other Observations There are situations in addition to single case reports of "serious" adverse events or reactions that may necessitate rapid com… |
| ICH ICH E2A Guideline 1994 III B. - III C. | G | III B. - III C. | EN | CLINICAL SAFETY DATA MANAGEMENT: DEFINITIONS AND STANDARDS FOR EXPEDITED REPORTING
III. STANDARDS FOR EXPEDITED REPORTING B. Reporting Time Frames 1.… |
| ICH ICH E2A Guideline 1994 III E | G | III E | EN | Miscellaneous Issues
1. Reactions Associated with Active Comparator or Placebo Treatment It is the sponsor's responsibility to decide whether active c… |
